The role of molecular diagnostic testing in the management of thyroid nodules.

about

The role of molecular diagnostic testing in the management of thyroid nodules.

Item

http://www.wikidata.org/entity/Q39250953

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The role of molecular diagnostic testing in the management of thyroid nodules.

@en

The role of molecular diagnostic testing in the management of thyroid nodules.

@nl

type

Item

label

The role of molecular diagnostic testing in the management of thyroid nodules.

@en

The role of molecular diagnostic testing in the management of thyroid nodules.

@nl

prefLabel

The role of molecular diagnostic testing in the management of thyroid nodules.

@en

The role of molecular diagnostic testing in the management of thyroid nodules.

@nl

P1476

The role of molecular diagnostic testing in the management of thyroid nodules.

@en

P2093

Brendan M Finnerty

http://www.w3.org/2001/XMLSchema#string

Katherine D Gray

http://www.w3.org/2001/XMLSchema#string

Maureen D Moore

http://www.w3.org/2001/XMLSchema#string

Rasa Zarnegar

http://www.w3.org/2001/XMLSchema#string

Suraj Panjwani

http://www.w3.org/2001/XMLSchema#string

Thomas J Fahey

http://www.w3.org/2001/XMLSchema#string

P2860

Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma

BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis

Progress in molecular-based management of differentiated thyroid cancer

Mutations of the BRAF gene in human cancer

Next-generation sequencing: advances and applications in cancer diagnosis

Integrated genomic characterization of papillary thyroid carcinoma

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors

New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway

The changing incidence of thyroid cancer.

Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.

P304

567-576

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737159.2017.1321987

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28423960

http://www.w3.org/2001/XMLSchema#string